Publicaciones en las que colabora con EVA ALLONCA CAMPA (10)

2020

  1. Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma

    Oral Oncology, Vol. 110

2019

  1. The multikinase inhibitor EC-70124 synergistically increased the antitumor activity of doxorubicin in sarcomas

    International Journal of Cancer, Vol. 145, Núm. 1, pp. 254-266

2018

  1. Distinctive expression and amplification of genes at 11q13 in relation to HPV status with impact on survival in head and neck cancer patients

    Journal of Clinical Medicine, Vol. 7, Núm. 12

  2. Immunohistochemical expression of cortactin and focal adhesion kinase predicts recurrence risk and laryngeal cancer risk beyond histologic grading

    Cancer Epidemiology Biomarkers and Prevention, Vol. 27, Núm. 7, pp. 805-813

2017

  1. A Novel Role for Nanog As An Early Cancer Risk Marker in Patients with Laryngeal Precancerous Lesions

    Scientific Reports, Vol. 7, Núm. 1

  2. Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma Models

    Neoplasia (United States), Vol. 19, Núm. 6, pp. 460-470

2016

  1. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas

    Oncotarget, Vol. 7, Núm. 20, pp. 29780-29793

  2. Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma

    Oncotarget, Vol. 7, Núm. 21, pp. 30935-30950

2014

  1. Immunohistochemical markers of distant metastasis in laryngeal and hypopharyngeal squamous cell carcinomas

    Clinical and Experimental Metastasis, Vol. 31, Núm. 3, pp. 317-325

2012

  1. Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas

    Modern Pathology, Vol. 25, Núm. 8, pp. 1069-1078